Product Description
Potassium clavulanate is the potassium salt of clavulanic acid, a highly specific β-lactamase inhibitor widely applied in the pharmaceutical industry. It exhibits minimal independent antibacterial activity but generates significant synergistic effects when compounded with common β-lactam antibiotics.
By suppressing bacterial enzyme hydrolysis, it protects companion antibiotics from invalidation, greatly broadening their antibacterial spectrum and enhancing therapeutic efficacy against resistant bacterial infections. Manufactured under rigorous quality control, this product boasts high purity, stable quality and full compliance with international pharmaceutical standards.
Product Parameters
| English Name | Potassium clavulanate |
| English Synonyms | CLAVULANATE POTASSIUM;CLAVULANIC ACID POTASSIUM;CLAVULANIC ACID POTASSIUM SALT;CLAVULA NTE POTASSIUM;MM 1415;Potassium Clavulanat;Clavulanate;4-Oxa-1-azabicyclo3.2.0heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monopotassium salt, (2R,3Z,5R) |
| CAS Number | 61177-45-5 |
| Molecular Formula | C8H10KNO5 |
| Molecular Weight | 239.27 |
| EINECS Number | 262-640-9 |
| Melting point | >1600C (dec) |
| Specific rotation | +55~+60° |
| Storage conditions | Inert atmosphere,2-8°C |
| Solubility | Easily soluble in water, slightly soluble in ethanol (96%), and very slightly soluble in acetone. |
| Form | Solid |
| Color | Light brown to brown |
| Main applications | agriculture clinical environmental forensics and toxicology pharmaceutical (small molecule) |
| InChI | InChl=1/C8H9NO5.K.H/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4;/h1,6-7,10H,2-3H2,(H,12,13);/b4-1-/t6-,7 -/s3 |
| InChIKey | ABVRVIZBZKUTMK-JSYANWSFSA-M |
| SMILES | C([C@H]1/CV/O[C@]2([H])CC(=O)N12)=C/CO)(=O)O.[KH] [&1:1,4,r |
Application Scenarios
Pharmaceutical Production – Primarily formulated with active ingredients such as amoxicillin to prepare compound antibiotic drugs, widely used for clinical treatment of various bacterial infectious diseases.
Pharmaceutical R&D – Commonly adopted in the research and development of novel anti-drug-resistance antibacterial agents, providing core raw material support for solving clinical antibiotic resistance problems.
Product Highlights
With reliable safety, stable efficacy and standardized quality attributes, potassium clavulanate has become a mainstream synergistic agent in global antibacterial preparations. It effectively improves the utilization efficiency of antibiotics and provides stable, high-quality raw material guarantees for clinical medication and pharmaceutical industrial production.
